ImmuCell Corporation Inventory
ImmuCell Corporation (ICCC) had Inventory of $9.08 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-13
- 2026-06-30: Inventory, Net $9.08M.
- 2026-03-31: Inventory, Net $8.67M.
- 2025-12-31: Inventory, Net $9.27M.
- 2025-09-30: Inventory, Net $9.80M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $9.08M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $8.67M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $9.27M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $9.80M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $8.29M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $7.36M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $7.11M 10-K · filed 2026-03-30 |
| 2024-09-30 | $7.46M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $7.30M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $7.15M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $7.81M 10-K · filed 2025-03-28 |
| 2023-09-30 | $7.39M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $7.54M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $6.33M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $6.04M 10-K · filed 2024-04-01 |
| 2022-09-30 | $5.32M 10-Q · filed 2022-11-21 |
| 2022-06-30 | $4.60M 10-Q/A · filed 2022-11-21 |
| 2022-03-31 | $3.44M 10-Q/A · filed 2022-11-21 |
| 2021-12-31 | $3.09M 10-K · filed 2023-03-29 |
| 2021-09-30 | $2.67M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.42M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.12M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $2.09M 10-K · filed 2022-03-30 |
| 2020-09-30 | $2.09M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.89M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $1.60M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $2.52M 10-K · filed 2021-03-30 |
| 2019-09-30 | $2.68M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.49M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $2.04M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $2.33M 10-K · filed 2020-03-27 |
| 2018-09-30 | $2.25M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $1.84M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $1.93M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $2.05M 10-K · filed 2019-03-22 |
| 2017-09-30 | $2.73M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $2.62M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $2.10M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $2.13M 10-K · filed 2018-03-29 |
| 2016-09-30 | $1.77M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $1.23M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $980.90K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $870.21K 10-K · filed 2017-03-30 |
| 2015-09-30 | $864.44K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $646.11K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $578.66K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $945.75K 10-K · filed 2016-03-25 |
| 2014-09-30 | $1.04M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $944.20K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $947.33K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $1.21M 10-K · filed 2015-03-26 |
| 2013-09-30 | $1.49M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $1.57M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $1.44M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $1.65M 10-K · filed 2014-03-26 |
| 2012-09-30 | $1.80M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $1.67M 10-Q/A · filed 2012-09-07 |
| 2012-03-31 | $1.58M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $1.67M 10-K · filed 2013-03-28 |
| 2011-09-30 | $1.76M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $1.64M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $1.60M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |